Stroke prevention in atrial fibrillation: an update on current management strategies
Atrial Fibrillation Friday, March 22nd, 2013Minerva Medica: March 1, 2013
Department of Cardiology, Princess Alexandra Hospital, University of Queensland, Brisbane, Australia
Stroke attributed to atrial fibrillation (AF) confers significant morbidity and mortality. In the past, warfarin has been the only successful stroke prevention agent available. However, it is often underutilized due to its well-known limitations, leaving many patients without adequate stroke protection. The last decade has seen significant strides forward in the field of anticoagulation for AF. Read more
